Metformin controlled-release/sitagliptin - Galenicum Health
Alternative Names: Metformin/sitagliptin extended-release - Galenicum Health; Sitagliptin/metformin controlled-release - Galenicum HealthLatest Information Update: 15 Dec 2023
At a glance
- Originator Galenicum Health
- Class Antihyperglycaemics; Biguanides; Insulin sensitisers; Pyrazines; Small molecules; Triazoles
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors; Glucose modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Type 2 diabetes mellitus
Most Recent Events
- 13 Feb 2023 Galenicum Health completes phase I trial in Type 2 diabetes mellitus (In volunteers) in Mexico (PO) (NCT06124547)